Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-08-11
1999-12-14
Woodward, Michael P.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514307, 514311, 514314, 514406, 514407, 514872, A61K 3100
Patent
active
060018070
ABSTRACT:
CRF-antagonists are useful in the treatment of emesis.
REFERENCES:
patent: 4605642 (1986-08-01), Rivier et al.
patent: 5668145 (1997-09-01), Bright
UENO et al., Life Sciences, vol. 41, pp. 513-518, (1987).
Borovian Joseph J.
Delacroix-Muirhad C.
Novartis AG
Woodward Michael P.
LandOfFree
Use of CRF-antagonists for treating emesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of CRF-antagonists for treating emesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of CRF-antagonists for treating emesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-863458